Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:35 AM
Ignite Modification Date:
2025-12-25 @ 2:35 AM
NCT ID:
NCT05752734
Brief Summary:
In the obese patient, adequate pain relief in the postoperative period is an important parameter that affects patient comfort and hospital stay. Increasing patient comfort and recovery quality can be achieved by avoiding undesirable effects such as nausea and vomiting, as well as analgesia. In our study, our aim is to evaluate the effect of dexamethasone added to multimodal analgesia on postoperative patient comfort in the obese patient group with a 40-item scale.
Detailed Description:
Postoperative pain prolongs hospital stay, delays wound healing, increases infection rates, and increases the incidence of drug side effects due to the use of systemic pain relievers (especially opioids).
Good pain control facilitates respiratory effort, allows the patient to perform respiratory exercises and cough to correct the increased thoracic fat mass and impaired respiratory mechanics due to anesthesia. The patient without pain is mobilized early and discharged early.
Our aim is to evaluate the effect of dexamethasone added to multimodal analgesia on postoperative patient comfort in the obese patient group with a 40-item scale.
Patients will be divided in to two groups (group D and group C):
Group D (Dexamethasone Group):
Patients who used/applied dexamethasone before bariatric surgery were included in this group.
Group C(Control Group):
Patients who did not use dexamethasone or steroid-derived drugs were included in this group.
The patients included in the study were evaluated with the 40-item recovery quality scale (QoR-40) 24 hours after the operation.
İn addition all patients will be administered iv morphine pca (patient controlled analgesia) for the first 24 hours postoperatively
Study:
NCT05752734
Study Brief:
Protocol Section:
NCT05752734